Journals / Van Tıp Dergisi / 2017 / Cilt: 24 - Sayı: 3

Current Approach to Menopause

Menopoza Güncel Yaklaşım

Pages
210–215
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While not being prescribed as often as in previous years, hormone replacement therapy is currently the most important method for relieving these symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:With the increase in the life span, the period of physiological menopause also extends.
📊
Key Findings & Data:Many health problems, especially vasomotor symptoms, will develop in the period of menopause.
💡
Conclusion & Impact:While not being prescribed as often as in previous years, hormone replacement therapy is currently the most important method for relieving these symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

With the increase in the life span, the period of physiological menopause also extends. Many health problems, especially vasomotor symptoms, will develop in the period of menopause. Therefore, the medical and paramedical methods developed are frequently updated. While not being prescribed as often as in previous years, hormone replacement therapy is currently the most important method for relieving these symptoms.

Özet

Yaşam süresinin artması ile fizyolojik menopoz dönemi de uzamıştır. Vazomotor semptomlar başta olmak üzere bir çok sağlık sorunu gelişecektir. Tüm bunlara karşın geliştirilen medikal ve paramedikal yöntemler sık olarak güncellenmektedir. Önceki yıllarda olduğu gibi sık reçete edilmemekle beraber hormon replasman tedavisi halen bu semptomların giderilmesinde en önemli yöntemdir.

🔖

Cite This Article

SAYAN, S., YILDIZHAN, R. (2017). Current Approach to Menopause. Van Tıp Dergisi, Cilt: 24 - Sayı: 3, 210–215. https://ajindex.com/articles/333966

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med 2006; 355(22): 2338-2347
  2. Avis NE, Stellato R, Crawford S, Bromberger J, Ganz P, Cain V, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001; 52(3): 345-356
  3. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001; 76(5): 874-878
  4. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014; 123(1): 202-216
  5. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999; 49(3): 138- 144
  6. Gunnarsdottir HK, Kjaerheim K, Boffetta P, Rafnsson V, Zahm SH. Women's Health: Occupation, Cancer, and Reproduction. A conference overview. Am J Ind Med 1999; 36(1): 1-5
  7. Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Johnston S, et al. Managing menopause. J Obstet Gynaecol Can 2014; 36(9): 830-833
  8. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005; 23(2): 117-125
  9. Campagnoli C, Morra G, Belforte P, Belforte L, Prelato Tousijn L. Climacteric symptoms according to body weight in women of different socio-economic groups. Maturitas 1981; 3(3-4): 279-287
  10. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51(6): 1492-1498
  11. Thurston RC, Sowers MR, Sutton-Tyrrell K, Everson-Rose SA, Lewis TT, Edmundowicz D, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008; 15(3): 429-434
  12. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010; 66(3): 285-290
  13. Park JK, Lim YH, Kim KS, Kim SG, Kim JH, Lim HG, et al. Body fat distribution after menopause and cardiovascular disease risk factors: Korean National Health and Nutrition Examination Survey 2010. J Womens Health (Larchmt) 2013; 22(7): 587-594
  14. Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005; 105(5 Pt 1): 1063-1073
  15. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanes